InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Kellen Scott, Chief Financial Officer. Officer active across 1 companies, notably DiaMedica Therapeutics Inc.. Cumulatively, 2 reports have been recorded. Total volume traded: €53k. The latest transaction was filed on 16 August 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€26,70910,000 shares@ €2.6709100.0% of flow
Voting Common Shares, no par value per share
SEC:0001235802-21-000097·
Ideal exit: 13 May 2022 (T+270)
€26,70910,000 shares@ €2.67090.0064% mcap50.0% of flow
Voting Common Shares, no par value per share
SEC:0001235802-21-000097:0·
Ideal exit: 13 May 2022 (T+270)
2 of 2 declarations
About Kellen Scott
Kellen Scott serves as the Chief Financial Officer and Secretary of DiaMedica Therapeutics Inc. In this role, he is responsible for the financial management of the company, including financial planning, risk management, and financial compliance. Kellen brings significant expertise in finance and plays a key role in DiaMedica's financial strategy, a company focused on developing treatments for neurological diseases.
